WEX Pharmaceuticals: Annual and Special Shareholders Meeting Update
September 8, 2006
Vancouver, BC - (September 7, 2006) - WEX Pharmaceuticals Inc. (“WEX” or the“Company”) confirms that the meeting materials for the upcoming Shareholders'
Meeting (“Meeting”) to be held on Friday, September 29, 2006 have been mailed
to its shareholders. A copy of the Information Circular is available on the
Company's website at www.wexpharma.com
In consultation with Dr. Cohen and Dr. du Souich, several amendments were made
to the matters to be considered at the Meeting, following a Circular mailed to
shareholders by them for the cancelled August meeting recommending that shareholders
vote against certain proposals. Additional information has also been provided
by the Company in response to questions raised by them in their Circular.
About WEX Pharmaceuticals Inc.
WEX Pharmaceuticals Inc. is dedicated to the discovery, development, manufacture
and commercialization of innovative drug products to treat pain. The Company's
principal business strategy is to derive drugs from naturally occurring toxins
and develop proprietary products for the global market. The Company's Chinese
subsidiary sells generic products manufactured at its facility in China. Forward Looking Statements and Information Certain statements herein may contain forward-looking statements and forward-looking
information within the meaning of applicable securities laws. Forward-looking
statements or information appear in a number of places and can be identified
by the use of words such as “plans”, “expects” or “does not expect”, “is expected”,
“budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or
“does not anticipate” or “believes” or variations of such words and phrases or
statements that certain actions, events or results “may”, “could”, “would”, “might”
or “will” be taken, occur or be achieved. Forward-looking statements and information
include statements regarding the proposed rights offering and are subject to
such risks, uncertainties and other factors which may cause our actual results,
performance or achievements, or industry results, to be materially different
from any future results, performance or achievements expressed or implied by
such forward-looking statements or information. See our annual information form
and our quarterly and annual management's discussion and analysis for additional
information on risks and uncertainties relating to the forward-looking statement
and information. There can be no assurance that forward-looking statements or
information referenced herein will prove to be accurate, as actual results and
future events could differ materially from those anticipated in such statements
or information. Also, many of the factors are beyond the control of the Company.
Accordingly, readers should not place undue reliance on forward-looking statements
or information. All forward-looking statements and information made herein,
are qualified by this cautionary statement.
For additional information on our products, visit us at www.wexpharma.com or
call Dr. Edge Wang, President & CEO at 604-683-8880 or 1-800-722-7549.
